October 12, 2022 by Chain Drug Review
candy corn, Halloween, Rite Aid
Leading Headlines
PHILADELPHIA – With Halloween lurking, Rite Aid released findings on consumers’ favorite trick-or-treating novelties and seasonal shopping habits, based on an examination of sales data from a year ago. Rite Aid says the data reveal unexpected insights around how Americans prepare for Halloween night. More than 2.8 million pounds of Halloween candy was purchased through
October 11, 2022 by Chain Drug Review
Google Cloud, Rite Aid
Featured Articles, Leading Headlines, Retail News
PHILADELPHIA — Rite Aid and Google Cloud are entering a multi-year technology partnership to help Rite Aid realize its vision of a modern pharmacy, the companies said on Tuesday. Google Cloud technologies will provide Rite Aid with better insights, increased agility and improved customer experiences, the companies added. Modernized applications for personalized digital experiences will
September 29, 2022 by Chain Drug Review
Rite Aid, second quarter
Leading Headlines, Retail News
PHILADELPHIA – Rite Aid had mixed second quarter results, reporting sales that beat analysts’ forecast but posting a wider than expected loss. The company ‘s $5.9 billion in revenue topped Wall Street’s prediction of $5.77 billion. But its adjusted 63 cents per share loss was worse than the anticipated 55 cents per share. For fiscal
September 15, 2022 by Chain Drug Review
Rite Aid, vaccinations
Featured Articles, Leading Headlines, Retail News
PHILADELPHIA – Getting vaccinated can be a family affair. Rite Aid will offer Family Immunization Days at select stores, including Bartell Drugs in the Pacific Northwest, providing families convenient opportunities to walk in and get the vaccinations they need to protect themselves against COVID-19, the flu and other diseases. Rite Aid Family Immunization Days are
September 12, 2022 by Chain Drug Review
Brian Hoover, Rite Aid, Steve Bixler
Leading Headlines, Retail News
PHILADELPHIA — Rite Aid announced on Monday that Steve Bixler, vice president of financial accounting, will become the new chief accounting officer effective Jan. 13, 2023, following the retirement of Brian Hoover who has served in the role for the last three years during his 27 years with Rite Aid. Bixler will report to chief
September 6, 2022 by Chain Drug Review
Rite Aid
Leading Headlines, Pharmacy, Retail News
PHILADELPHIA —Rite Aid announced Tuesday that scheduling is now available for the updated boosters of the mRNA Pfizer and Moderna COVID-19 vaccines at its locations and at Bartell Drugs locations in the Pacific Northwest. “At Rite Aid, we recognize the important role pharmacists continue to play in helping our communities fight COVID-19, and we look
August 25, 2022 by Chain Drug Review
Andre Persaud, Rite Aid
Leading Headlines, Retail News
PHILADELPHIA — Andre Persaud, chief retail officer at Rite Aid Corp. announced on his LinkedIn page the launch a new brand advertising campaign. “This is our first since rebranding in 2020. The ad highlights the consumer push and pull to be healthy but to also indulge and have fun. It reminds our customers that there
August 4, 2022 by Chain Drug Review
flu shots, Karen Staniforth, Rite Aid
Leading Headlines, Pharmacy
PHILADELPHIA — Rite Aid announced on Thursday that it has opened online scheduling for flu shots at its locations including Bartell Drugs in the Pacific Northwest, and is now accepting walk-ins, providing convenient options for families to get vaccinated. “With children going back to school, now is the perfect time to schedule a flu shot
July 26, 2022 by Chain Drug Review
100% cage-free eggs, Rite Aid, The Humane League
Leading Headlines, Retail News
NEW YORK — Rite Aid has accelerated progress toward its commitment to selling 100% cage-free eggs to year-end 2022. The company had initially pledged to source cage-free eggs across all its retail locations by 2025. The new commitment expedites the timeline by three years. “We commend Rite Aid for expediting its cage-free timeline to reduce
July 20, 2022 by Chain Drug Review
Rite Aid, Rite Aid has published its fourth annual Environmental, Social and Governance (ESG) report
Featured Articles, Leading Headlines, Retail News
PHILADELPHIA — Rite Aid has published its fourth annual Environmental, Social and Governance (ESG) Report, detailing the company’s strategy and progress against goals over the past year. This year’s report addresses the four ESG pillars introduced in the company’s 2021 report: Thriving Planet, Thriving Business, Thriving Workplace and Thriving Community. “As a purpose-driven healthcare organization,
July 19, 2022 by Chain Drug Review
Expand Access to COVID-19 PCR Testing Nationwide, Karen Staniforth, Quest Diagnostics, Rite Aid
Featured Articles, Leading Headlines, Pharmacy, Retail News
PHILADELPHIA — Rite Aid announced Tuesday that it is collaborating with Quest Diagnostics to provide access to quality COVID-19 molecular testing (polymerase chain reaction or similar nucleic acid amplification test) to help Rite Aid customers detect and prevent the spread of COVID-19. Quest is the world’s leading provider of diagnostic information services and a national
July 13, 2022 by Chain Drug Review
Heyward Donigan, Rite Aid
Leading Headlines, Retail News
PHILADELPHIA — Rite Aid unveiled its new headquarters in Philadelphia’s thriving Navy Yard district on Wednesday. The Rite Aid Collaboration Center, located on the second floor of 1200 Intrepid Avenue, will bring Rite Aid’s remote corporate workforce and associates together in a modern space with state-of-the-art amenities. The new headquarters, with its accessibility to major
June 27, 2022 by Chain Drug Review
CVS, Rite Aid
Leading Headlines, Retail News
NEW YORK — According to various reports, CVS and Rite Aid announced Monday that they are limiting the number of emergency contraceptive pills customers may purchase after the Supreme Court overturned the constitutional right to an abortion. CVS said that it is temporarily limiting purchases of so-called morning-after pills to three boxes per transaction to
June 23, 2022 by Chain Drug Review
Donigan, first quarter, Rite Aid
Featured Articles, Leading Headlines, Retail News
PHILADELPHIA — Rite Aid on Thursday reported a narrower first quarter loss and more revenue than analysts had expected. The company’s adjusted loss per share of 60 cents for the period ended May 28 was smaller than Wall Street’s consensus projection of a 70 cents. Sales of $6.01 billion beat the predicted $5.7 billion. Rite